| Code | CSB-MP884474HU |
| Abbreviation | Recombinant Human CDCP1 protein, partial (Active) |
| MSDS | |
| Size | $9.9 |
| Promotion | |
| Order now | |
| Image |
|
| Have Questions? | Leave a Message or Start an on-line Chat |
CDCP1 is a transmembrane receptor implicated in cancer cell migration, invasion, and metastatic progression, making it a target of interest in oncology research. This construct spans residues 30–667, encompassing the extracellular domain critical for antibody recognition and ligand interactions, and is expressed in mammalian cells to preserve native glycosylation and conformational epitopes. Functional ELISA validation demonstrates specific antibody binding with an EC50 of 0.29–0.44 ng/mL, confirming that the protein retains the structural integrity required for therapeutic antibody epitope mapping, competitive inhibition screening, and blocking antibody validation in cancer biology workflows. The combination of >95% purity and <1.0 EU/μg endotoxin meets the quality thresholds commonly required for surface plasmon resonance affinity characterization, bio-layer interferometry kinetic studies, and small-molecule or biologic inhibitor screening campaigns targeting CDCP1-mediated signaling pathways.
There are currently no reviews for this product.